Sign in

CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203857670
Phone
844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
  1. 4 Grant or award Chief Development Officer acquired 25,637 shares (grant or award)
  2. 4 Grant or award Chief Medical Officer acquired 25,637 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 100,100 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 37,604 shares (grant or award)
  5. 4 Open-market buy Director bought 9,375,000 shares at $3.20 ($30,000,000)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Chief Development Officer acquired 23,306 shares (grant or award)
  13. 4 Grant or award Chief Medical Officer acquired 23,306 shares (grant or award)
  14. 4 Grant or award President and CEO acquired 91,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 34,185 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 14 · 271 filings